Myelodysplastic Syndromes

Showing NaN - NaN of 57

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

MDS Trial in Worldwide (Tamibarotene + Azacitidine, Tamibarotene Matched Placebo + Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Tamibarotene + Azacitidine
  • Tamibarotene Matched Placebo + Azacitidine
  • Tucson, Arizona
  • +87 more
Feb 2, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)

Enrolling by invitation
  • Acute Myeloid Leukemia
  • +2 more
  • Fountain Valley, California
  • +28 more
Nov 18, 2022

MDS Trial in United States (Lenalidomide, Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Miami, Florida
  • +5 more
Sep 28, 2022

Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies Trial

Recruiting
  • Relapsed or Refractory Acute Myeloid Leukemia (AML)
  • +3 more
  • Birmingham, Alabama
  • +26 more
Sep 12, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +26 more
Aug 11, 2022

MDS Trial in Orlando, Tampa, Baltimore (SX-682)

Recruiting
  • Myelodysplastic Syndromes
  • Orlando, Florida
  • +2 more
Feb 18, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS Trial in Tampa, Baltimore, Bronx (TEW-7197)

Completed
  • Myelodysplastic Syndromes
  • Tampa, Florida
  • +2 more
Sep 22, 2021

MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (Guadecitabine, Treatment Choice)

Completed
  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic
  • Duarte, California
  • +95 more
Sep 1, 2021

MDS Trial in France, Germany, United States (Oral rigosertib)

Completed
  • Myelodysplastic Syndromes
  • Oral rigosertib
  • Stanford, California
  • +13 more
Jun 15, 2021

Connect® Myeloid Disease Registry

Recruiting
  • Primary Myelofibrosis
  • +2 more
    • Huntsville, Alabama
    • +228 more
    Mar 30, 2021

    MDS Trial in Canada, United States (anti-thymocyte globulin)

    Completed
    • Myelodysplastic Syndromes
    • anti-thymocyte globulin
    • Washington, District of Columbia
    • +27 more
    Jan 24, 2021

    MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • rigosertib sodium
    • Stanford, California
    • +34 more
    Jun 29, 2020

    MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)

    Completed
    • Myelodysplastic Syndromes
    • +3 more
    • ON 01910.Na
    • Scottsdale, Arizona
    • +86 more
    Jun 29, 2020

    MDS Trial in Germany, United States (lenalidomide)

    Completed
    • Myelodysplastic Syndromes
    • Scottsdale, Arizona
    • +31 more
    Nov 6, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure)

    Completed
    • Leukemia
    • +3 more
    • daclizumab
    • +4 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    Oct 31, 2019

    Anemia, GVHD, Leukemia Trial in Baltimore (biological, drug, procedure, radiation)

    Completed
    • Anemia
    • +5 more
    • anti-thymocyte globulin
    • +6 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    Oct 15, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (biological, drug, procedure, radiation)

    Completed
    • Leukemia
    • +3 more
    • anti-thymocyte globulin
    • +5 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    Oct 15, 2019

    Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (filgrastim, therapeutic allogeneic lymphocytes,

    Completed
    • Leukemia
    • +3 more
    • filgrastim
    • +3 more
    • Baltimore, Maryland
      Marlene & Stewart Greenebaum Cancer Center, University of Maryla
    Oct 15, 2019

    Leukemia, MDS Trial in Atlanta, Baltimore (bevacizumab, cytarabine, mitoxantrone HCl)

    Completed
    • Leukemia
    • Myelodysplastic Syndromes
    • bevacizumab
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Oct 15, 2019

    MDS Trial in Baltimore (K562/GM-CSF cell vaccine)

    Terminated
    • Myelodysplastic Syndromes
    • K562/GM-CSF cell vaccine
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Oct 18, 2018

    Leukemia, MDS, Myelodysplastic/Myeloproliferative Diseases Trial in Baltimore (biological, drug, genetic, other, procedure)

    Completed
    • Leukemia
    • +2 more
    • sargramostim
    • +6 more
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Sep 7, 2018